comparemela.com

Latest Breaking News On - Duration of treatment - Page 1 : comparemela.com

Bispecifics in Multiple Myeloma: Dosing and Transition of Care

A brief review of logistical considerations that play a part in selecting novel therapy for patients with multiply relapsed multiple myeloma.

Evolving treatment paradigmMultiple myelomaRecent updatesMyeloma cancerRelapsed refractory multiple myelomaMultiply relapsedLater line treatmentLater line therapyFixed duration therapyDuration of therapyDuration of treatmentStep up dosingPriming dosesDose scheduleDosing scheduleAccess to care

Coverage Considerations for Oral SERDs

Drs Langer and Vidula describe the coverage considerations for the diagnostic test required for the use of oral selective estrogen receptor degraders, best practices associated with its use, and the recommended duration of treatment.

Neelima vidulaLucyr langerRyan haumschildEstrogen receptors degradersEr her2 metastatic breast cancerProgression free survivalDuration of treatmentEsr1 pathophysiology

Treatment Duration in Patients With Newly Diagnosed Multiple Myeloma

A panel of experts reflects on treatment duration and its role in optimizing management of patients with newly diagnosed multiple myeloma.

Evolving treatment paradigmMultiple myelomaRecent updatesPatients with newly diagnosed multipleMyeloma cancerNewly diagnosed multiple myelomaGriffin trialGriffin studyMaster trialMcmaster studyDuration of therapyDuration of treatmentDiscontinuing therapyStopping therapyFixed duration therapyMinimal residual disease

Meaningful End Points for Patients with Metastatic Melanoma

Experts on skin cancer discuss valuable end points for determining successful treatments for patients with metastatic melanoma.

Sunandana chandraAnnac pavlickNikhil khushalaniUnresectable metastatic melanomaTrial end pointsRadiographic evidenceStable diseaseOverall survivalProgression free survivalComplete responseTreatment free intervalDuration of treatment

vimarsana © 2020. All Rights Reserved.